$EVH
Evolent Health, Inc. Stock $evh

$evh Overview Financials Valuation SEC Filings Company Website

2017 Q3 Form 10-Q Financial Statement

#000162890817000052 Filed on November 09, 2017

Income Statement

Concept	2017 Q3	2016 Q4	2016 Q3
Revenue	$107.9M	$88.01M	$60.21M
YoY Change	79.23%	91.09%	49.01%
Cost Of Revenue	$68.30M	$59.90M	$33.90M
YoY Change	101.47%	142.51%	36.69%
Gross Profit	$39.60M	$28.10M	$26.30M
YoY Change	50.57%	31.92%	68.59%
Gross Profit Margin	36.7%	31.93%	43.68%
Selling, General & Admin	$45.83M	$57.60M	$38.40M
YoY Change	19.37%	77.78%	28.71%
% of Gross Profit	115.74%	204.98%	146.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.300M	$6.490M	$900.0K
YoY Change	155.56%	107.35%	80.0%
% of Gross Profit	5.81%	23.1%	3.42%
Operating Expenses	$121.9M	$121.9M	$76.05M
YoY Change	60.33%	102.31%	31.91%
Operating Profit	-$14.02M	-$93.78M	-$15.84M
YoY Change	-11.48%	140.81%	-8.16%
Interest Expense	$880.0K	-$500.0K	$0.00
YoY Change		-350.0%	-100.0%
% of Operating Profit
Other Income/Expense, Net	$15.00K	$0.00	$1.000K
YoY Change	1400.0%
Pretax Income	-$14.84M	-$34.30M	-$16.03M
YoY Change	-7.41%	145.0%	-6.75%
Income Tax	-$1.714M	-$9.100M	-$300.0K
% Of Pretax Income
Net Earnings	-$12.59M	-$17.41M	-$11.21M
YoY Change	12.31%	322.6%	-6.44%
Net Earnings / Revenue	-11.67%	-19.78%	-18.61%
Basic Earnings Per Share	-$0.18	-$0.33	-$0.26
Diluted Earnings Per Share	-$0.18	-$0.33	-$0.26
COMMON SHARES
Basic Shares Outstanding	70.33M shares		43.11M shares
Diluted Shares Outstanding	70.33M shares		43.11M shares

Balance Sheet

Concept	2017 Q3	2016 Q4	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$287.1M	$178.9M	$159.5M
YoY Change	80.0%	15.27%	-24.12%
Cash & Equivalents	$287.1M	$134.6M	$109.8M
Short-Term Investments	$0.00	$44.30M	$49.70M
Other Short-Term Assets	$21.20M	$45.40M	$10.00M
YoY Change	112.0%	410.11%	81.82%
Inventory
Prepaid Expenses
Receivables	$43.97M	$40.64M	$21.99M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$352.3M	$265.0M	$191.4M
YoY Change	84.05%	43.64%	-22.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$46.93M	$31.18M	$21.12M
YoY Change	122.17%	143.66%	96.4%
Goodwill	$628.3M	$626.6M	$459.7M
YoY Change	36.68%	2.9%	-24.5%
Intangibles	$249.5M	$258.9M	$162.8M
YoY Change	53.26%	58.7%	-1.73%
Long-Term Investments	$700.0K	$2.200M	$2.500M
YoY Change	-72.0%	-95.07%	-88.64%
Other Assets	$9.364M	$10.04M	$12.12M
YoY Change	-22.73%		14678.05%
Total Long-Term Assets	$946.7M	$934.9M	$659.9M
YoY Change	43.47%	12.49%	-18.53%
TOTAL ASSETS
Total Short-Term Assets	$352.3M	$265.0M	$191.4M
Total Long-Term Assets	$946.7M	$934.9M	$659.9M
Total Assets	$1.299B	$1.200B	$851.3M
YoY Change	52.6%	18.15%	-19.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$27.29M	$43.89M	$14.49M
YoY Change	88.4%	162.84%	14.59%
Accrued Expenses	$21.09M	$29.16M	$11.84M
YoY Change	78.17%	382.22%	-45.4%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$105.5M	$131.9M	$65.33M
YoY Change	61.44%	121.73%	-27.28%
LONG-TERM LIABILITIES
Long-Term Debt	$121.2M	$120.3M	$0.00
YoY Change
Other Long-Term Liabilities	$9.982M	$14.66M	$7.997M
YoY Change	24.82%	13102.7%	11835.82%
Total Long-Term Liabilities	$9.982M	$14.66M	$7.997M
YoY Change	24.82%	13102.7%	11835.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$105.5M	$131.9M	$65.33M
Total Long-Term Liabilities	$9.982M	$14.66M	$7.997M
Total Liabilities	$243.3M	$287.7M	$91.42M
YoY Change	166.07%	255.5%	-23.9%
SHAREHOLDERS EQUITY
Retained Earnings	$99.11M	$146.6M	$164.0M
YoY Change	-39.58%	-52.19%	-47.23%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.020B	$702.5M	$562.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.299B	$1.200B	$851.3M
YoY Change	52.6%	18.15%	-19.4%

Cashflow Statement

Concept	2017 Q3	2016 Q4	2016 Q3
OPERATING ACTIVITIES
Net Income	-$12.59M	-$17.41M	-$11.21M
YoY Change	12.31%	322.6%	-6.44%
Depreciation, Depletion And Amortization	$2.300M	$6.490M	$900.0K
YoY Change	155.56%	107.35%	80.0%
Cash From Operating Activities	$3.820M	-$21.50M	$7.910M
YoY Change	-51.71%	240.73%	-224.57%
INVESTING ACTIVITIES
Capital Expenditures	-$8.920M	-$4.410M	-$3.860M
YoY Change	131.09%	68.97%	33.56%
Acquisitions
YoY Change
Other Investing Activities	$23.55M	-$69.42M	-$500.0K
YoY Change	-4810.0%	32.96%	-75.37%
Cash From Investing Activities	$14.63M	-$73.84M	-$4.350M
YoY Change	-436.32%	34.7%	-11.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	163.5M	149.3M	1.080M
YoY Change	15041.67%	2898.19%	2060.0%
NET CHANGE
Cash From Operating Activities	3.820M	-21.50M	7.910M
Cash From Investing Activities	14.63M	-73.84M	-4.350M
Cash From Financing Activities	163.5M	149.3M	1.080M
Net Change In Cash	182.0M	53.97M	4.640M
YoY Change	3821.98%	-196.12%	-141.39%
FREE CASH FLOW
Cash From Operating Activities	$3.820M	-$21.50M	$7.910M
Capital Expenditures	-$8.920M	-$4.410M	-$3.860M
Free Cash Flow	$12.74M	-$17.09M	$11.77M
YoY Change	8.24%	361.89%	-440.17%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	0	USD
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Evolent Health, Inc.
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001628908
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	evh	Abandonment Amortization AbandonmentAmortization	360000	USD
	evh	Abandonment Amortization AbandonmentAmortization	1239000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1600000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1614000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	879000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3802000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2100000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	365000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1179000	USD
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	0	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3802000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-908000	USD
CY2016	evh	Adjustmentsto Additional Paidin Capital Adjustmentfrom Adoptionof New Accounting Principle AdjustmentstoAdditionalPaidinCapitalAdjustmentfromAdoptionofNewAccountingPrinciple	0	USD
CY2016Q3	evh	Business Acquisition Pro Forma Net Income Loss Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossAttributabletoNoncontrollingInterest	-4067000	USD
	evh	Business Acquisition Pro Forma Net Income Loss Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossAttributabletoNoncontrollingInterest	-52604000	USD
CY2016Q3	evh	Business Acquisition Pro Forma Net Income Loss Including Portion Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossIncludingPortionAttributabletoNoncontrollingInterest	-16247000	USD
	evh	Business Acquisition Pro Forma Net Income Loss Including Portion Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossIncludingPortionAttributabletoNoncontrollingInterest	-205483000	USD
CY2017Q3	evh	Cash Fdic Insured Amount Percentage CashFDICInsuredAmountPercentage	0.742
CY2017Q3	evh	Cash Held In Money Market Funds Percentage CashHeldInMoneyMarketFundsPercentage	0.258
CY2016Q3	evh	Costof Goodsand Services Sold Excluding Depreciationand Amortization CostofGoodsandServicesSoldExcludingDepreciationandAmortization	33905000	USD
	evh	Costof Goodsand Services Sold Excluding Depreciationand Amortization CostofGoodsandServicesSoldExcludingDepreciationandAmortization	95294000	USD
CY2017Q3	evh	Costof Goodsand Services Sold Excluding Depreciationand Amortization CostofGoodsandServicesSoldExcludingDepreciationandAmortization	68281000	USD
	evh	Costof Goodsand Services Sold Excluding Depreciationand Amortization CostofGoodsandServicesSoldExcludingDepreciationandAmortization	203804000	USD
CY2016	evh	Fair Value Inputs Longterm Revenue Growth Rate Theoretical Recurring Revenue FairValueInputsLongtermRevenueGrowthRateTheoreticalRecurringRevenue	1000000	USD
	evh	Fair Value Inputs Longterm Revenue Growth Rate Theoretical Recurring Revenue FairValueInputsLongtermRevenueGrowthRateTheoreticalRecurringRevenue	1000000	USD
CY2016Q3	evh	Income Lossfrom Equity Method Investments Services Agreement IncomeLossfromEquityMethodInvestmentsServicesAgreement	100000	USD
	evh	Income Lossfrom Equity Method Investments Services Agreement IncomeLossfromEquityMethodInvestmentsServicesAgreement	100000	USD
CY2017Q3	evh	Income Lossfrom Equity Method Investments Services Agreement IncomeLossfromEquityMethodInvestmentsServicesAgreement	100000	USD
	evh	Income Lossfrom Equity Method Investments Services Agreement IncomeLossfromEquityMethodInvestmentsServicesAgreement	400000	USD
CY2016	evh	Liabilities Subject To Compromise Impact Of Lease Termination LiabilitiesSubjectToCompromiseImpactOfLeaseTermination	0	USD
CY2016	evh	Liabilities Subject To Compromise Payments For Early Contract Termination Fees LiabilitiesSubjectToCompromisePaymentsForEarlyContractTerminationFees	0	USD
	evh	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Measurement Period Adjustment NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationMeasurementPeriodAdjustment	0	USD
	evh	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Measurement Period Adjustment NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationMeasurementPeriodAdjustment	1766000	USD
	evh	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issued Value NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedValue	10534000	USD
	evh	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issued Value NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedValue	0	USD
CY2016Q4	evh	Prepaid Expenseand Other Assets Current Related Parties PrepaidExpenseandOtherAssetsCurrentRelatedParties	4507000	USD
CY2017Q3	evh	Prepaid Expenseand Other Assets Current Related Parties PrepaidExpenseandOtherAssetsCurrentRelatedParties	37000	USD
	evh	Proceeds From Issuance Of Common Stock Net Of Payments Of Stock Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfPaymentsOfStockIssuanceCosts	0	USD
	evh	Proceeds From Issuance Of Common Stock Net Of Payments Of Stock Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfPaymentsOfStockIssuanceCosts	166947000	USD
CY2016	evh	Risk Adjusted Recurring Revenue Compound Annual Growth Rate Period RiskAdjustedRecurringRevenueCompoundAnnualGrowthRatePeriod	P5Y
	evh	Risk Adjusted Recurring Revenue Compound Annual Growth Rate Period RiskAdjustedRecurringRevenueCompoundAnnualGrowthRatePeriod	P5Y
	evh	Stock Issued Decrease In Deferred Tax Liability StockIssuedDecreaseInDeferredTaxLiability	1606000	USD
	evh	Stock Issued Decrease In Deferred Tax Liability StockIssuedDecreaseInDeferredTaxLiability	12992000	USD
CY2016	evh	Stock Issued During Period Conversionof Convertible Securities Tax Impact StockIssuedDuringPeriodConversionofConvertibleSecuritiesTaxImpact	1606000	USD
	evh	Stock Issued During Period New Issues Tax Impact StockIssuedDuringPeriodNewIssuesTaxImpact	12992000	USD
CY2016	evh	Stock Issued During Period Value Acceleration Of Equity Awards As Part Of Business Combination StockIssuedDuringPeriodValueAccelerationOfEquityAwardsAsPartOfBusinessCombination	3899000	USD
CY2016	evh	Stock Issued During Period Value Acquisitions Tax Effect StockIssuedDuringPeriodValueAcquisitionsTaxEffect	1427000	USD
	evh	Tax Benefit Related To Intangible Assets TaxBenefitRelatedToIntangibleAssets	0	USD
	evh	Tax Benefit Related To Intangible Assets TaxBenefitRelatedToIntangibleAssets	2042000	USD
CY2017Q3	evh	Tax Receivables Agreement Percentof Tax Savingstobe Paid TaxReceivablesAgreementPercentofTaxSavingstobePaid	0.85
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	43892000	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	27292000	USD
CY2016Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	13480000	USD
CY2017Q3	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	12120000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40635000	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	43972000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29160000	USD
CY2017Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	21094000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5236000	USD
CY2017Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11279000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	555250000	USD
CY2017Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	919962000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16147000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16172000	USD
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4799000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13844000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5708000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16172000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	685000	USD
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2700000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7900000	USD
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5300000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15000000	USD
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20754000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19265000	shares
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11408000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17635000	shares
CY2016Q4	us-gaap	Assets Assets	1199839000	USD
CY2017Q3	us-gaap	Assets Assets	1299030000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	264966000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	352329000	USD
CY2016Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.24
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-3.04
CY2016Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.24
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-3.04
CY2016Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-12180000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-152879000	USD
CY2016Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	91936000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	262233000	USD
CY2016Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2017Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	100000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	300000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	374000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	83000	USD
CY2016Q3	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	400000	USD
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	900000	USD
CY2017Q3	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1200000	USD
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	2800000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	145726000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109777000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	134563000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	287143000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-35949000	USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	28220000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	152580000	USD
CY2017Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	295900000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	168883000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	196000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1614000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2668000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	20481000	USD
CY2017Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	26094000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	20846000	USD
CY2017Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	6638000	USD
CY2016Q3	us-gaap	Depreciation Depreciation	900000	USD
	us-gaap	Depreciation Depreciation	2400000	USD
CY2017Q3	us-gaap	Depreciation Depreciation	2300000	USD
	us-gaap	Depreciation Depreciation	6000000	USD
CY2016Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3746000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10728000	USD
CY2017Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7717000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	21236000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10728000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	21236000	USD
CY2016Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	8258000	USD
CY2017Q3	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	5740000	USD
CY2016Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	3211000	USD
CY2017Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	796000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.34
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.78
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.34
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.78
CY2016Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.016
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.008
CY2017Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.116
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.035
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	38408000	USD
CY2017Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	30987000	USD
CY2016Q3	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
CY2017Q3	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-100000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-300000	USD
CY2016Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	0	USD
CY2016Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	7750000	USD
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2016Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7750000	USD
CY2016Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7750000	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	8300000	USD
CY2017Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	8500000	USD
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	8600000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	18400000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	33362000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	277323000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	282854000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	258923000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	249492000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	608903000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	626569000	USD
CY2017Q3	us-gaap	Goodwill Goodwill	628341000	USD
CY2016	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	178266000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2016Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	160600000	USD
CY2016Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	160600000	USD
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	160600000	USD
CY2017Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2016	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	0	USD
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	1772000	USD
CY2016Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	44341000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	197000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	35000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	44503000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	44341000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	44503000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16031000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-203199000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14843000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-57986000	USD
CY2016Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-448000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-462000	USD
CY2017Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-369000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1446000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-256000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-300000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1700000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1714000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2009000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3692000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	10591000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1605000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5075000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6165000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-11075000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2882000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	4835000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-638000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-7707000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	117000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1719000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	112000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5125000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1194000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	2164000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	258923000	USD
CY2017Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	249492000	USD
CY2015Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	169000000	USD
CY2016Q3	us-gaap	Interest Expense InterestExpense	0	USD
	us-gaap	Interest Expense InterestExpense	0	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	880000	USD
	us-gaap	Interest Expense InterestExpense	2781000	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Interest Paid InterestPaid	1222000	USD
CY2016Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	255000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	805000	USD
CY2017Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	411000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	813000	USD
CY2016Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	2159000	USD
CY2017Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	712000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	287725000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	243251000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1199839000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1299030000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	131941000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	105467000	USD
CY2015Q4	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	0	USD
CY2016Q4	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	6100000	USD
CY2017Q3	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	0	USD
CY2016	us-gaap	Liabilities Subject To Compromise Expense Reversal Of Expense For Liabilities LiabilitiesSubjectToCompromiseExpenseReversalOfExpenseForLiabilities	6460000	USD
	us-gaap	Liabilities Subject To Compromise Expense Reversal Of Expense For Liabilities LiabilitiesSubjectToCompromiseExpenseReversalOfExpenseForLiabilities	0	USD
CY2016Q3	us-gaap	License And Services Revenue LicenseAndServicesRevenue	52453000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	139918000	USD
CY2017Q3	us-gaap	License And Services Revenue LicenseAndServicesRevenue	99708000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	297422000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	120283000	USD
CY2017Q3	us-gaap	Long Term Debt LongTermDebt	121164000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	209588000	USD
CY2017Q3	us-gaap	Minority Interest MinorityInterest	35932000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	169570000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22823000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	17003000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14005000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33993000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-11208000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-142335000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-12588000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-47506000	USD
CY2016Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4567000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-59250000	USD
CY2017Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-541000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8471000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11208000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-142335000	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12588000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-47506000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11208000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-142335000	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-12588000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-47506000	USD
CY2016	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	0	USD
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	0	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	76049000	USD
	us-gaap	Operating Expenses OperatingExpenses	369723000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	121932000	USD
	us-gaap	Operating Expenses OperatingExpenses	375814000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-15839000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-203546000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-14020000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-54593000	USD
CY2016Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1100000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	3400000	USD
CY2017Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	3000000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	8000000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10043000	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9364000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14655000	USD
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9982000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-443000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-388000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	15000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	21000	USD
CY2016Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2100000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	14000000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	3694000	USD
CY2017Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	300000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1500000	USD
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	3000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11116000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21349000	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	-13129000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11011000	USD
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16144000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	4099000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	44210000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1244000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	-15775000	USD
	us-gaap	Profit Loss ProfitLoss	-201585000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-226778000	USD
	us-gaap	Profit Loss ProfitLoss	-55977000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	36415000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	58209000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31179000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	46930000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	40416000	USD
CY2017Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	16932000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1050000	USD
CY2017Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3712000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	4950000	USD
CY2017Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	8150000	USD
CY2016Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	34416000	USD
CY2017Q3	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	5070000	USD
CY2016Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	6000000	USD
CY2017Q3	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	11862000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	146617000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	99111000	USD
CY2016Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	60210000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	166177000	USD
CY2017Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	107912000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	321221000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	38398000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	103101000	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	45834000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	150474000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	13844000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	16172000	USD
CY2015Q3	us-gaap	Share Price SharePrice	19.51
CY2015Q4	us-gaap	Share Price SharePrice	14.73
CY2016Q1	us-gaap	Share Price SharePrice	10.33
CY2016Q4	us-gaap	Short Term Investments ShortTermInvestments	44341000	USD
CY2017Q3	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2016	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	177782000	USD
CY2016	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2017Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	166947000	USD
CY2016	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	2193000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-1179000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1259000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	702526000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	1019847000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	934579000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	912114000	USD
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1055779000	USD
CY2016Q3	us-gaap	Technology Services Revenue TechnologyServicesRevenue	7757000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	26259000	USD
CY2017Q3	us-gaap	Technology Services Revenue TechnologyServicesRevenue	8204000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	23799000	USD
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43110000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42632000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70328000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60867000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43110000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42632000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	70328000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60867000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting Estimates and Assumptions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions affecting the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses for the reporting period. Those estimates are inherently subject to change and actual results could differ from those estimates. In the accompanying consolidated financial statements, estimates are used for, but not limited to, the valuation of assets, liabilities, consideration related to business combinations and asset acquisitions, revenue recognition including discounts and credits, estimated selling prices for deliverables in multiple element arrangements, contingent payments, allowance for doubtful accounts, depreciable lives of assets, impairment of long lived assets (including equity method investments), stock-based compensation, deferred income taxes and valuation allowance, contingent liabilities, valuation of intangible assets (including goodwill), purchase price allocation in taxable stock transactions and the useful lives of intangible assets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div>

Files In Submission

Name	View Source	Status
0001628908-17-000052-index-headers.html	Edgar Link	pending
0001628908-17-000052-index.html	Edgar Link	pending
0001628908-17-000052.txt	Edgar Link	pending
0001628908-17-000052-xbrl.zip	Edgar Link	pending
a093017exhibit311.htm	Edgar Link	pending
a093017exhibit312.htm	Edgar Link	pending
a093017exhibit321.htm	Edgar Link	pending
a093017exhibit322.htm	Edgar Link	pending
evh-20170930.xml	Edgar Link	completed
evh-20170930.xsd	Edgar Link	pending
evh-20170930_cal.xml	Edgar Link	unprocessable
evh-20170930_def.xml	Edgar Link	unprocessable
evh-20170930_lab.xml	Edgar Link	unprocessable
evh-20170930_pre.xml	Edgar Link	unprocessable
evh09301710-q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EVH
Evolent Health, Inc. Stock $evh

2017 Q3 Form 10-Q Financial Statement

#000162890817000052 Filed on November 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVH Evolent Health, Inc. Stock $evh

2017 Q3 Form 10-Q Financial Statement

#000162890817000052 Filed on November 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVH
Evolent Health, Inc. Stock $evh